Grzegorz Kreiner, PhD


Grzegorz Kreiner, PhD
Position
Specialist

Assistant professor at Institute of Pharmacology PAS, Dept. Brain Biochemistry. Principal Investigator on two research grants funded by National Science Center (NCN):

Opus7 2014/13/B/NZ7/02293: Evaluation of the role of transcription factor CREB in the mechanism of antidepressant treatment: study on the novel genetic models based on the Cre/loxP system (2015-2018)

Opus13 2017/25/B/NZ7/02406: Evaluation of the influence of progressive noradrenergic neurodegeneration on dopaminergic system functioning in context of presymptomatic phase of Parkinson's disease (2018-2021)



More publications
  • Evaluation of the influence of progressive noradrenergic neurodegeneration on dopaminergic system functioning in context of presymptomatic phase of Parkinson's disease. - 2018-01-03 - 2021-01-02
    OPUS13 2017/25/B/NZ7/02406
    Principal Investigator: Dr Grzegorz Kreiner
  • Evaluation of the role of transcription factor CREB in the mechanisms antidepressant treatment - 2015-01-27 - 2018-11-26
    OPUS7 2014/13/B/NZ7/02293
    Principal Investigator: Dr Grzegorz Kreiner
  • Pharmacological evaluation of possible neuroprotective strategies in novel genetic mouse models of progressive neurodegeneration, based on tissue specific inducible Cre/loxP system - 2012-08-22 - 2016-04-21
    OPUS2 2011/03/B/NZ7/05949
    Principal Investigator: Dr Grzegorz Kreiner
  • Investigation of noradrenergic and glucocorticoid system interactions in GRDBHCre mice and their evaluation as a potential model of depression - 2010-02-01 - 2014-12-31
    POIG 01.01.02-12-004/09 DeMeTer (Depression – Mechanisms – Therapy). 
    Task 1.1 Subtask 1.1.2. Main topic: Modelling of depression – strategy of learning about its aetiology. Principal Investigator of task 1.2: Dr Grzegorz Kreiner

National

International

  • Dr Andrii Domanskyi, Institute of Biotechnology, University of Helsinki, Finland
  • Dr Rosanna Parlato, Institute of Applied Physiology, University of Ulm, Germany